NCT00015080

Naltrexone in Treatment of Cocaine Dependence - 5

Naltrexone in Treatment of Cocaine Dependence

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 0 (planned)
• Sponsor: National Institute on Drug Abuse (NIDA) · NIH
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the efficacy of naltrexone in the treatment of cocaine dependence as measured by: 1) decreased urine benzoylecgonine (BE) levels, 2) decreased cocaine use by self-report, 3) decreased cocaine craving, and 4) retention in treatment.

Detailed description

Double-blind, placebo controlled study of the safety and efficacy of naltrexone in treating cocaine dependence in a patient sample that initiated the study while in an inpatient setting and were then followed-up for 3 months as outpatients.

Conditions

• Cocaine-Related Disorders

Interventions

Type	Name	Description
DRUG	Naltrexone

Timeline

• Start date: 1995-05-01
• Primary completion: 1996-06-01
• Completion: 1996-07-01
• First posted: 2001-04-18
• Last updated: 2017-01-16

Locations

1 site across 1 country: United States